Antiseizure Drugs Flashcards
Phenytoin
Fosphenytoin
Mechanism of action
Block high-frequency firing of neurons through action on voltage-gated (VG) Na+ Channels, decreases synaptic release of glutamate
Cyclic ureides
Phenytoin
Fosphenytoin
Phenobarbital
Ethosuximide
Block high-frequency firing of neurons through action on voltage-gated (VG) Na+ Channels, decreases synaptic release of glutamate
Phenytoin (Cyclic ureide)
Fosphenytoin (Cyclic ureide)
Carbamazepine (Tricyclic)
Mechanism of action
Phenytoin
Fosphenytoin
Pharmacokinetics
Absorption is formulation dependent, highly bound to plasma proteins, no active metabolites, dose-dependent elimination, t 1/2 12-36 h, fosphenytoin is for IV, IM routes
Absorption is formulation dependent, highly bound to plasma proteins, no active metabolites, dose-dependent elimination, t 1/2 12-36 h, fosphenytoin is for IV, IM routes
Phenytoin
Fosphenytoin
Pharmacokinetics
Phenytoin, Fosphenytoin
Clinical applications
Generalized tonic-clonic seizures, partial seizures
Generalized tonic-clonic seizures, partial seizures
Phenytoin, Fosphenytoin (Cyclic ureides)
Carbamazepine, Oxcarbazepine (Tricyclics)
Clinical applications
Phenytoin
Fosphenytoin
Toxicities, Interactions
TOXICITY: Diplopia, ataxia, gingival hyperplasia, hirsutism, neuropathy, INTERACTIONS: Phenobarbital, carbamazepine, isoniazid, felbamate, oxcarbazepine, topiramate, fluoxetine, fluconazole, digoxin, quinidine, cyclosporine, steroids, oral contraceptives, other
TOXICITY: Diplopia, ataxia, gingival hyperplasia, hirsutism, neuropathy, INTERACTIONS: Phenobarbital, carbamazepine, isoniazid, felbamate, oxcarbazepine, topiramate, fluoxetine, fluconazole, digoxin, quinidine, cyclosporine, steroids, oral contraceptives, other
Phenytoin
Fosphenytoin
Toxicities, Interactions
Ethosuximide
Mechanism of action
Reduces low-threshold Ca2+ currents (T-type)
Reduces low-threshold Ca2+ currents (T-type)
Ethosuximide
Mechanism of action
Ethosuximide
Pharmacokinetics
Well absorbed orally, with peak levels in 3-7 h, not protein bound, completely metabolized to inactive compounds, t 1/2 typically 40 h
Well absorbed orally, with peak levels in 3-7 h, not protein bound, completely metabolized to inactive compounds, t 1/2 typically 40 h
Ethosuximide
Pharmacokinetics
Ethosuximide
Clinical applications
Absence seizures
Absence seizures
Ethosuximide
Clinical applications
Ethosuximide
Toxicities, Interactions
TOXICITY: Nausea, headache, dizziness, hyperactivity, INTERACTIONS: Valproate, phenobarbital, phenytoin, carbamazepine, rifampicin
TOXICITY: Nausea, headache, dizziness, hyperactivity, INTERACTIONS: Valproate, phenobarbital, phenytoin, carbamazepine, rifampicin
Ethosuximide
Toxicities, Interactions
Tricyclics
Carbamazepine
Oxcarbazepine
Eslicarbazepine acetate
Carbamazepine
Oxcarbazepine
Eslicarbazepine acetate
Tricyclics
Carbamazepine
Mechanism of action
Block high-frequency firing of neurons through action on voltage-gated (VG) Na+ Channels, decreases synaptic release of glutamate
Carbamazepine
Pharmacokinetics
Well absorbed orally, with peak levels 6-8 h, no significant protein binding, metabolized in part to active 10-11-epoxide, t 1/2 of parent ranges from 8 to 12 h in treated patiens to 36 h in normal subjects
Well absorbed orally, with peak levels 6-8 h, no significant protein binding, metabolized in part to active 10-11-epoxide, t 1/2 of parent ranges from 8 to 12 h in treated patiens to 36 h in normal subjects
Carbamazepine
Pharmacokinetics
Carbamazepine
Clinical applications
Generalized tonic-clonic seizures, partial seizures
Carbamazepine
Toxicities, Interactions
TOXICITY: Nausea, diplopia, ataxia, hyponatremia, headache, INTERACTIONS: Phenytoin, carbamazepine, valproate, fluoxetine, verapamil, macrolide antibiotics, isoniazid, propoxyphene, danazol, phenobarbital, primidone, many other
TOXICITY: Nausea, diplopia, ataxia, hyponatremia, headache, INTERACTIONS: Phenytoin, carbamazepine, valproate, fluoxetine, verapamil, macrolide antibiotics, isoniazid, propoxyphene, danazol, phenobarbital, primidone, many other
Carbamazepine
Toxicities, Interactions
GABA derivatives
Gabapenin
Pregabalin
Vigabatrin
Vigabatrin
GABA derivative
Pregabalin
GABA derivative
Gabapenin
GABA derivative
Gabapenin
Pregabalin
Mechanism of action
Decreases excitatory transmission by acting on Voltage gated Ca2+ Channels presynaptically (a2g subunit)
Decreases excitatory transmission by acting on Voltage gated Ca2+ Channels presynaptically (a2g subunit)
Gabapenin
Pregabalin
Mechanism of action
Gabapenin
Pregabalin
Clinical applications
Generalized tonic-clonic seizures, partial seizures, generalized seizures
Generalized tonic-clonic seizures, partial seizures, generalized seizures
Gabapenin
Pregabalin
Clinical applications
Valproate
Mechanism of action
Blocks high-frequency firing of neurons, modifies amino acid metabolism
Blocks high-frequency firing of neurons, modifies amino acid metabolism
Valproate
Mechanism of action
Valproate
Clinical applications
Generalized tonic-clonic seizures, partial seizures, generalized seizures, absence seizures, myoclonic seizures
Generalized tonic-clonic seizures, partial seizures, generalized seizures, absence seizures, myoclonic seizures
Valproate
Clinical applications
Lamotrigine
Mechanism of action
Prolongs inactivation of voltage gated (VG) Na+ Channels, acts presynaptically on VG Ca2+ Channels, decreasing glutamate release
Prolongs inactivation of voltage gated (VG) Na+ Channels, acts presynaptically on VG Ca2+ Channels, decreasing glutamate release
Lamotrigine
Mechanism of action
Lamotrigine
Clinical applications
Generalized tonic-clonic seizures, generalized seizures, partial seizures, absence seizures
Generalized tonic-clonic seizures, generalized seizures, partial seizures, absence seizures
Lamotrigine
Clinical applications